Relevant bibliographies by topics / T807 / Journal articles
To see the other types of publications on this topic, follow the link: T807.

Journal articles on the topic 'T807'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'T807.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Gandy, Sam, and Steven T. DeKosky. "[18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy." F1000Research 3 (September 29, 2014): 229. http://dx.doi.org/10.12688/f1000research.5372.1.

Full text
Abstract:
A new molecular ligand for positron emission tomography (PET) of the human brain, [18F]-T807, is under investigation for the antemortem detection of pathological neurofibrillary aggregates, which are evidence of neurofibrillary tangle (NFT) diseases, also known as tauopathies. Repetitive mild traumatic brain injuries in athletes and battlefield veterans are associated with one such tauopathy, known as chronic traumatic encephalopathy (CTE). In a recent case report, a former NFL player with clinically probable CTE and a concurrent Progressive Supranuclear Palsy (PSP) –like syndrome was studied
APA, Harvard, Vancouver, ISO, and other styles
2

Lemoine, Laetitia, Per-Göran Gillberg, Marie Svedberg, et al. "Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains." Alzheimer's Research & Therapy 9, no. 1 (2017): 96. https://doi.org/10.1186/s13195-017-0325-z.

Full text
Abstract:
<strong>Background: </strong>The aim of this study was to compare the binding properties of several tau positron emission tomography tracers—THK5117, THK5351, T807 (also known as AV1451; flortaucipir), and PBB3—head to head in the same human brain tissue.<strong>Methods: </strong>Binding assays were performed to compare the regional distribution of <sup>3</sup>H-THK5117 and <sup>3</sup>H-THK5351 in postmortem tissue from three Alzheimer's disease (AD) cases and three control subjects in frontal and temporal cortices as well as in the hippocampus. Competition binding assays between THK5351, THK
APA, Harvard, Vancouver, ISO, and other styles
3

Declercq, Lieven, Sofie Celen, Joan Lecina, et al. "Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807." Molecular Imaging 15 (January 2016): 153601211562492. http://dx.doi.org/10.1177/1536012115624920.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mintun, Mark, and M. Pontecorvo. "Update on Tau imaging with F18-T807." Neurobiology of Aging 35 (March 2014): S16. http://dx.doi.org/10.1016/j.neurobiolaging.2014.01.090.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Carlsson, Lena E., Sentot Santoso, Carsten Spitzer, Christof Kessler та Andreas Greinacher. "The 2 Gene Coding Sequence T807/A873 of the Platelet Collagen Receptor Integrin 2β1 Might Be a Genetic Risk Factor for the Development of Stroke in Younger Patients". Blood 93, № 11 (1999): 3583–86. http://dx.doi.org/10.1182/blood.v93.11.3583.

Full text
Abstract:
Abstract The polymorphisms C807T and G873A of the platelet integrin 2β1 (collagen receptor glycoprotein [GP] Ia-IIa) are linked to the expression density of this receptor. The GPIa T807/A873 allele causes a higher receptor expression, enhancing platelet binding to collagen. This might present a genetic predisposition for the development of thromboembolic complications. In this case-control study, the genotypes of the GPIa C807T polymorphism and presence of conventional risk factors (hypertension, diabetes mellitus, and smoking) were compared in stroke patients and patients without cerebrovasc
APA, Harvard, Vancouver, ISO, and other styles
6

Carlsson, Lena E., Sentot Santoso, Carsten Spitzer, Christof Kessler та Andreas Greinacher. "The 2 Gene Coding Sequence T807/A873 of the Platelet Collagen Receptor Integrin 2β1 Might Be a Genetic Risk Factor for the Development of Stroke in Younger Patients". Blood 93, № 11 (1999): 3583–86. http://dx.doi.org/10.1182/blood.v93.11.3583.410k34_3583_3586.

Full text
Abstract:
The polymorphisms C807T and G873A of the platelet integrin 2β1 (collagen receptor glycoprotein [GP] Ia-IIa) are linked to the expression density of this receptor. The GPIa T807/A873 allele causes a higher receptor expression, enhancing platelet binding to collagen. This might present a genetic predisposition for the development of thromboembolic complications. In this case-control study, the genotypes of the GPIa C807T polymorphism and presence of conventional risk factors (hypertension, diabetes mellitus, and smoking) were compared in stroke patients and patients without cerebrovascular dise
APA, Harvard, Vancouver, ISO, and other styles
7

Foulkes, Jennifer E., Moses Prabu-Jeyabalan, Deyna Cooper, et al. "Role of Invariant Thr80 in Human Immunodeficiency Virus Type 1 Protease Structure, Function, and Viral Infectivity." Journal of Virology 80, no. 14 (2006): 6906–16. http://dx.doi.org/10.1128/jvi.01900-05.

Full text
Abstract:
ABSTRACT Sequence variability associated with human immunodeficiency virus type 1 (HIV-1) is useful for inferring structural and/or functional constraints at specific residues within the viral protease. Positions that are invariant even in the presence of drug selection define critically important residues for protease function. While the importance of conserved active-site residues is easily understood, the role of other invariant residues is not. This work focuses on invariant Thr80 at the apex of the P1 loop of HIV-1, HIV-2, and simian immunodeficiency virus protease. In a previous study, w
APA, Harvard, Vancouver, ISO, and other styles
8

Shoup, Timothy M., Daniel L. Yokell, Peter A. Rice, et al. "A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807." Journal of Labelled Compounds and Radiopharmaceuticals 56, no. 14 (2013): 736–40. http://dx.doi.org/10.1002/jlcr.3098.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zimmer, Eduardo Rigon, Antoine Leuzy, Serge Gauthier, and Pedro Rosa-Neto. "Developments in Tau PET Imaging." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 41, no. 5 (2014): 547–53. http://dx.doi.org/10.1017/cjn.2014.15.

Full text
Abstract:
ABSTRACTThe presence of neurofibrillary tangles in the brain is a hallmark feature of several neurodegenerative diseases termed “tauopathies,” including Alzheimer’s disease (AD) and the tau molecular subgroup of frontotemporal lobar degeneration (FTLD-tau). Recently, several positron emission tomography (PET) radiopharmaceuticals targeting abnormal conformations of the tau protein have been developed. To date, six novel tau imaging agents—[18F]THK523, [18F]THK5105, [18F]THK5117, [18F]T807, [18F]T808, and [11C]PBB3—have been described and are considered promising as potential tau radioligands.
APA, Harvard, Vancouver, ISO, and other styles
10

Friedrichsen, Karl A., Tammie L. S. Benzinger, Nelly Joseph-Mathurin, et al. "P2-154: Patterns of tau binding in T807-PET imaging." Alzheimer's & Dementia 11, no. 7S_Part_11 (2015): P546. http://dx.doi.org/10.1016/j.jalz.2015.06.693.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Friedrichsen, Karl A., Tammie L. S. Benzinger, Nelly Joseph-Mathurin, et al. "IC-P-164: Patterns of tau binding in T807-PET imaging." Alzheimer's & Dementia 11, no. 7S_Part_2 (2015): P110. http://dx.doi.org/10.1016/j.jalz.2015.06.187.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Holt, Daniel P., Hayden T. Ravert, and Robert F. Dannals. "Synthesis and quality control of [18F]T807 for tau PET imaging." Journal of Labelled Compounds and Radiopharmaceuticals 59, no. 10 (2016): 411–15. http://dx.doi.org/10.1002/jlcr.3425.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Santoso, S., T. J. Kunicki, H. Kroll, W. Haberbosch, and A. Gardemann. "Association of the Platelet Glycoprotein Ia C807T Gene Polymorphism With Nonfatal Myocardial Infarction in Younger Patients." Blood 93, no. 8 (1999): 2449–53. http://dx.doi.org/10.1182/blood.v93.8.2449.

Full text
Abstract:
Abstract Recently, we have shown that two alleles of the glycoprotein (GP) Ia gene, designated C807 and T807, are associated with low or high platelet GPIa-IIa density and consequently with slower or faster rate of platelet adhesion to type I collagen, respectively. This polymorphism could therefore present a genetic predisposition for the development of thrombotic disease and hemostasis. We investigated the relationship of the GPIa C807T dimorphism to the risk of coronary artery disease (CAD) and myocardial infarction (MI). An allele-specific polymerase chain reaction (PCR) was developed for
APA, Harvard, Vancouver, ISO, and other styles
14

Santoso, S., T. J. Kunicki, H. Kroll, W. Haberbosch, and A. Gardemann. "Association of the Platelet Glycoprotein Ia C807T Gene Polymorphism With Nonfatal Myocardial Infarction in Younger Patients." Blood 93, no. 8 (1999): 2449–53. http://dx.doi.org/10.1182/blood.v93.8.2449.408k34_2449_2453.

Full text
Abstract:
Recently, we have shown that two alleles of the glycoprotein (GP) Ia gene, designated C807 and T807, are associated with low or high platelet GPIa-IIa density and consequently with slower or faster rate of platelet adhesion to type I collagen, respectively. This polymorphism could therefore present a genetic predisposition for the development of thrombotic disease and hemostasis. We investigated the relationship of the GPIa C807T dimorphism to the risk of coronary artery disease (CAD) and myocardial infarction (MI). An allele-specific polymerase chain reaction (PCR) was developed for genotypin
APA, Harvard, Vancouver, ISO, and other styles
15

Choi, Jae Yong, Chul Hyoung Lyoo, Jae Hoon Lee, et al. "Human Radiation Dosimetry of [18F]AV-1451(T807) to Detect Tau Pathology." Molecular Imaging and Biology 18, no. 4 (2016): 479–82. http://dx.doi.org/10.1007/s11307-015-0924-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Chhatwal, Jasmeer P., Aaron P. Schultz, Gad A. Marshall, et al. "Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly." Neurology 87, no. 9 (2016): 920–26. http://dx.doi.org/10.1212/wnl.0000000000003050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Gao, Mingzhang, Min Wang, and Qi-Huang Zheng. "Fully automated synthesis of [18F]T807, a PET tau tracer for Alzheimer’s disease." Bioorganic & Medicinal Chemistry Letters 25, no. 15 (2015): 2953–57. http://dx.doi.org/10.1016/j.bmcl.2015.05.035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Dickerson, Brad, Sara Makaretz, Christina Caso, et al. "P2-151: Imaging tau pathology in vivo in ftld with [18F] T807 PET." Alzheimer's & Dementia 11, no. 7S_Part_11 (2015): P545. http://dx.doi.org/10.1016/j.jalz.2015.06.690.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Kim, Hee Jin, Hanna Cho, Young Kyoung Jang, et al. "IC-P-200: [18 F] T807 PET Imaging in Subcortical Vascular Cognitive Impairment." Alzheimer's & Dementia 12 (July 2016): P144. http://dx.doi.org/10.1016/j.jalz.2016.06.231.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

von Beckerath, Nicolas, Werner Koch, Julinda Mehilli, Corinna Böttiger, Albert Schömig, and Adnan Kastrati. "Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting." Blood 95, no. 11 (2000): 3297–301. http://dx.doi.org/10.1182/blood.v95.11.3297.

Full text
Abstract:
Abstract The glycoprotein complex Ia/IIa (GP Ia/IIa) is a major collagen receptor on platelets and other cell types. Recently, linked polymorphisms within the coding region of the GP Ia gene (C807T and G873A) were identified that are related to GP Ia/IIa surface expression. The T807/A873 allele is associated with high expression, whereas the C807/G873 allele is associated with low surface expression of GP Ia/IIa. Subsequently, the T807 allele was found to be associated with coronary and cerebral infarction in younger patients. Platelet adhesion to the vessel wall plays a pivotal role in thromb
APA, Harvard, Vancouver, ISO, and other styles
21

von Beckerath, Nicolas, Werner Koch, Julinda Mehilli, Corinna Böttiger, Albert Schömig, and Adnan Kastrati. "Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting." Blood 95, no. 11 (2000): 3297–301. http://dx.doi.org/10.1182/blood.v95.11.3297.011k20_3297_3301.

Full text
Abstract:
The glycoprotein complex Ia/IIa (GP Ia/IIa) is a major collagen receptor on platelets and other cell types. Recently, linked polymorphisms within the coding region of the GP Ia gene (C807T and G873A) were identified that are related to GP Ia/IIa surface expression. The T807/A873 allele is associated with high expression, whereas the C807/G873 allele is associated with low surface expression of GP Ia/IIa. Subsequently, the T807 allele was found to be associated with coronary and cerebral infarction in younger patients. Platelet adhesion to the vessel wall plays a pivotal role in thrombosis afte
APA, Harvard, Vancouver, ISO, and other styles
22

Chien, David T., Shadfar Bahri, A. Katrin Szardenings, et al. "Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807." Journal of Alzheimer's Disease 34, no. 2 (2013): 457–68. http://dx.doi.org/10.3233/jad-122059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Xia, Chun-Fang, Janna Arteaga, Gang Chen, et al. "[18 F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease." Alzheimer's & Dementia 9, no. 6 (2013): 666–76. http://dx.doi.org/10.1016/j.jalz.2012.11.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Leuzy, Antoine, Eduardo Zimmer, Arturo Aliaga, et al. "IN VITRO QUANTIFICATION OF TAU PATHOLOGY IN ALZHEIMER'S DISEASE: AN [18F]T807 AUTORADIOGRAPHIC STUDY." Alzheimer's & Dementia 10 (July 2014): P116—P117. http://dx.doi.org/10.1016/j.jalz.2014.05.224.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Leuzy, Antoine, Eduardo Rigon Zimmer, Arturo Aliaga, et al. "IN VITRO QUANTIFICATION OF TAU PATHOLOGY IN ALZHEIMER'S DISEASE: AN [18F]T807 AUTORADIOGRAPHIC STUDY." Alzheimer's & Dementia 10 (July 2014): P308—P309. http://dx.doi.org/10.1016/j.jalz.2014.05.248.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Parsons, Michael, Liesel Von Imhof, Ryan Eckbo, et al. "NCOG-34. BRAIN PET IMAGING OF PAIRED HELICAL FILAMENT TAU IN OLDER ADULTS WITH CANCER: PILOT STUDY TO IDENTIFY MECHANISMS OF COGNITIVE IMPAIRMENT AFTER CANCER THERAPY." Neuro-Oncology 25, Supplement_5 (2023): v221. http://dx.doi.org/10.1093/neuonc/noad179.0847.

Full text
Abstract:
Abstract BACKGROUND Cancer-related cognitive impairment (CRCI) occurs in up to 75% of patients treated with chemotherapy for systemic cancer, and older patients treated for CNS cancer receiving brain radiation therapy (RT) and chemotherapy are particularly at risk. The mechanisms of injury and CRCI remain unknown. In neurodegenerative disorders, deposition of paired helical filament tau (PHFTau) is correlated with nature and extent of cognitive symptoms. The role of PHFTau in CRCI has not been elucidated. We conducted a pilot study to determine whether CRCI is associated with PHFTau. METHODS P
APA, Harvard, Vancouver, ISO, and other styles
27

Lemoine, Laetitia, Per-Göran Gillberg, Marie Svedberg, et al. "COMPARISON OF BINDING PROPERTIES OF THK5117, THK5351, PBB3 AND T807 IN AUTOPSIES OF ALZHEIMER DISEASE CASES." Alzheimer's & Dementia 13, no. 7 (2017): P139—P140. http://dx.doi.org/10.1016/j.jalz.2017.06.2564.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Dickerson, Brad, Kimiko Domoto-Reilly, Sapolsky Daisy, Michael Brickhouse, Michael Stepanovic, and Keith Johnson. "O1-02-01: IMAGING TAU PATHOLOGY IN VIVO IN FTLD: INITIAL EXPERIENCE WITH [18F] T807 PET." Alzheimer's & Dementia 10 (July 2014): P131. http://dx.doi.org/10.1016/j.jalz.2014.04.062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Johnson, Keith A., Aaron Schultz, Alex Becker, et al. "F4-01-04: TAU PET USING F18-T807: INITIAL EXPERIENCE IN NORMAL ELDERLY AND AD DEMENTIA." Alzheimer's & Dementia 10 (July 2014): P242. http://dx.doi.org/10.1016/j.jalz.2014.04.365.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Dickerson, Brad, Kimiko Domoto-Reilly, Sapolsky Daisy, Michael Stepanovic, Michael Brickhouse, and Keith Johnson. "IC-P-213: IMAGING TAU PATHOLOGY IN VIVO IN FTLD: INITIAL EXPERIENCE WITH [18F] T807 PET." Alzheimer's & Dementia 10 (July 2014): P115. http://dx.doi.org/10.1016/j.jalz.2014.05.221.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Gao, Chunhong, Wei Gong, Meiyan Yang, et al. "T807-modified human serum albumin biomimetic nanoparticles for targeted drug delivery across the blood–brain barrier." Journal of Drug Targeting 28, no. 10 (2020): 1085–95. http://dx.doi.org/10.1080/1061186x.2020.1777420.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Shcherbinin, Sergey, Michael D. Devous, Adam J. Schwarz, Abhinay D. Joshi, Michael Navitsky, and Mark A. Mintun. "IC-P-171: Region-dependent kinetics of the Tau PET tracer [18 F]-AV-1451 (T807)." Alzheimer's & Dementia 11, no. 7S_Part_2 (2015): P113. http://dx.doi.org/10.1016/j.jalz.2015.06.194.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Shcherbinin, Sergey, Michael D. Devous, Adam J. Schwarz, Abhinay D. Joshi, Michael Navitsky, and Mark A. Mintun. "O4-07-04: Region-dependent kinetics of the Tau PET tracer [18 F]-AV-1451 (T807)." Alzheimer's & Dementia 11, no. 7S_Part_6 (2015): P284—P285. http://dx.doi.org/10.1016/j.jalz.2015.07.384.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Marquié, Marta, Marc D. Normandin, Charles R. Vanderburg, et al. "Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue." Annals of Neurology 78, no. 5 (2015): 787–800. http://dx.doi.org/10.1002/ana.24517.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Wooten, Dustin W., Nicolas J. Guehl, Eline E. Verwer, et al. "Pharmacokinetic Evaluation of the Tau PET Radiotracer 18 F-T807 ( 18 F-AV-1451) in Human Subjects." Journal of Nuclear Medicine 58, no. 3 (2016): 484–91. http://dx.doi.org/10.2967/jnumed.115.170910.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Dickstein, D. L., M. Y. Pullman, C. Fernandez, et al. "Cerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy." Translational Psychiatry 6, no. 9 (2016): e900-e900. http://dx.doi.org/10.1038/tp.2016.175.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Devous, Michael D., Abhinay D. Joshi, Michael A. Navitsky, et al. "P4-314: TEST-RETEST DATA FOR THE TAU PET IMAGING AGENT 18F-AV-1451 (PREVIOUSLY, 18F-T807)." Alzheimer's & Dementia 10 (July 2014): P901. http://dx.doi.org/10.1016/j.jalz.2014.07.085.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

McGinnis, Scott M., Sara Makaretz, Christina Caso, Michael Stepanovic, Keith A. Johnson, and Brad Dickerson. "P4-064: Longitudinal 18 F-T807 PET imaging in a case of nonfluent variant primary progressive aphasia." Alzheimer's & Dementia 11, no. 7S_Part_17 (2015): P791—P792. http://dx.doi.org/10.1016/j.jalz.2015.06.1769.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Vermeiren, Céline, Joël Mercier, Delphine Viot, et al. "O4-07-01: T807, a reported selective tau tracer, binds with nanomolar affinity to monoamine oxidase a." Alzheimer's & Dementia 11, no. 7S_Part_6 (2015): P283. http://dx.doi.org/10.1016/j.jalz.2015.07.381.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Gandy, Samuel, Dara Dickstein, Mariel Pullman, et al. "[P4-232]: TAU IMAGING WITH [18 F]T807/AV-1451 IN ATHLETES WITH POST-CONCUSSIVE COMPLAINT AND CONTROLS." Alzheimer's & Dementia 13, no. 7S_Part_28 (2017): P1361. http://dx.doi.org/10.1016/j.jalz.2017.06.2100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Lemoine, Laetitia, Per-Göran Gillberg, Marie Svedberg, et al. "[P4-274]: COMPARISON OF BINDING PROPERTIES OF THK5117, THK5351, PBB3 AND T807 IN AUTOPSIES OF ALZHEIMER DISEASE CASES." Alzheimer's & Dementia 13, no. 7S_Part_28 (2017): P1390. http://dx.doi.org/10.1016/j.jalz.2017.06.2143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Xia, Chenjie, Sara Makaretz, Christina Caso, et al. "O4-01-05: The relationship between cortical atrophy and tau pathology measured in vivo with [18F] T807 PET." Alzheimer's & Dementia 11, no. 7S_Part_6 (2015): P267—P268. http://dx.doi.org/10.1016/j.jalz.2015.07.349.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Devous, Michael D., Abhinay D. Joshi, Michael Navitsky, et al. "IC-P-165: Understanding the topology of 18 F-AV-1451 (also known as T807) PET tau images in Alzheimer's disease." Alzheimer's & Dementia 11, no. 7S_Part_2 (2015): P110—P111. http://dx.doi.org/10.1016/j.jalz.2015.06.188.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Devous, Michael D., Abhinay D. Joshi, Michael Navitsky, et al. "O4-07-02: Understanding the topology of 18 F-AV-1451 (also known as T807) PET tau images in Alzheimer's disease." Alzheimer's & Dementia 11, no. 7S_Part_6 (2015): P283—P284. http://dx.doi.org/10.1016/j.jalz.2015.07.382.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Shcherbinin, S., A. J. Schwarz, A. Joshi, et al. "Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease." Journal of Nuclear Medicine 57, no. 10 (2016): 1535–42. http://dx.doi.org/10.2967/jnumed.115.170027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Liang, Steven H., Daniel L. Yokell, Marc D. Normandin, et al. "First Human Use of a Radiopharmaceutical Prepared by Continuous-Flow Microfluidic Radiofluorination: Proof of Concept with the Tau Imaging Agent [18F]T807." Molecular Imaging 13, no. 8 (2014): 7290.2014.00025. http://dx.doi.org/10.2310/7290.2014.00025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Coakeley, Sarah, Sang Soo Cho, Yuko Koshimori, et al. "Positron emission tomography imaging of tau pathology in progressive supranuclear palsy." Journal of Cerebral Blood Flow & Metabolism 37, no. 9 (2016): 3150–60. http://dx.doi.org/10.1177/0271678x16683695.

Full text
Abstract:
Progressive supranuclear palsy is a rare form of atypical Parkinsonism that differs neuropathologically from other parkinsonian disorders. While many parkinsonian disorders such as Parkinson’s disease, Lewy body dementia, and multiple system atrophy are classified as synucleinopathies, progressive supranuclear palsy is coined a tauopathy due to the aggregation of pathological tau in the brain. [18F]AV-1451 (also known as [18F]-T807) is a positron emission tomography radiotracer that binds to paired helical filaments of tau in Alzheimer’s disease. We investigated whether [18F]AV-1451 could be u
APA, Harvard, Vancouver, ISO, and other styles
48

Huang, Ya-Yao, Ming-Jang Chiu, Ruoh-Fang Yen, et al. "An one-pot two-step automated synthesis of [18F]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans." PLOS ONE 14, no. 7 (2019): e0217384. http://dx.doi.org/10.1371/journal.pone.0217384.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Chhatwal, Jasmeer P., Aaron P. Schultz, Gad A. Marshall, et al. "IC-P-162: Entorhinal, parahippocampal, and inferior temporal F18-T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly." Alzheimer's & Dementia 11, no. 7S_Part_2 (2015): P109. http://dx.doi.org/10.1016/j.jalz.2015.06.185.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Chhatwal, Jasmeer P., Aaron P. Schultz, Gad A. Marshall, et al. "O4-01-04: Entorhinal, parahippocampal, and inferior temporal F18-T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly." Alzheimer's & Dementia 11, no. 7S_Part_6 (2015): P267. http://dx.doi.org/10.1016/j.jalz.2015.07.348.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'T807' for other source types:
Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography